VA Cooperative Studies Program Controlled Substances Import Application
Summary
The DEA published a notice that VA Cooperative Studies Program, located in Albuquerque, New Mexico, applied on April 9, 2026, to be registered as an importer of Schedule I controlled substances Marihuana Extract (drug code 7350) and Tetrahydrocannabinols (drug code 7370). The company plans to import finished dosage unit products solely for research and clinical trial studies; no commercial sale of FDA-approved or non-approved finished dosage forms is authorized under this registration. Registered bulk manufacturers and applicants may submit comments or objections to the issuance of the proposed registration on or before May 21, 2026.
What changed
The DEA published a notice in the Federal Register announcing that VA Cooperative Studies Program applied to be registered as an importer of two Schedule I controlled substance basic classes: Marihuana Extract (7350) and Tetrahydrocannabinols (7370). The import authorization is limited strictly to finished dosage unit products for research and clinical trial studies; it does not extend to FDA-approved or non-approved finished dosage forms for commercial sale, per 21 U.S.C. 952(a)(2).
Registered bulk manufacturers of the affected basic classes and other applicants may file electronic comments or written objections to the proposed registration, or request a hearing, on or before May 21, 2026. All comments must be submitted through regulations.gov, and hearing requests must be sent to the DEA Hearing Clerk/OALJ and DEA Federal Register Representative at the Springfield, Virginia address.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Content
ACTION:
Notice of application.
SUMMARY:
VA Cooperative Studies Program has applied to be registered as an importer of basic class(es) of controlled substance(s).
Refer to
Supplementary Information
listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on
or objections to the issuance of the proposed registration on or before May 21, 2026. Such persons may also file a written
request for a hearing on the application on or before May 21, 2026.
ADDRESSES:
The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file
for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive
a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit
the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ,
8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration,
Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.34(a), this is notice that on April 9, 2026, VA Cooperative Studies Program, 2401 Centre Avenue
Southeast, Albuquerque, New Mexico 87106, applied to be registered as an importer of the following basic class(es) of controlled
substance(s):
| Controlled substance | Drug
code | Schedule |
| --- | --- | --- |
| Marihuana Extract | 7350 | I |
| Tetrahydrocannabinols | 7370 | I |
The company plans to import finished dosage unit products containing the above listed controlled substances for research and
clinical trial studies only. No other activities for these drug codes are authorized for this registration.
Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved
finished dosage forms for commercial sale.
Thomas Prevoznik, Deputy Assistant Administrator. [FR Doc. 2026-07697 Filed 4-20-26; 8:45 am] BILLING CODE P
Download File
CFR references
Parties
Related changes
Get daily alerts for Regs.gov: Drug Enforcement Administration
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from DEA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when Regs.gov: Drug Enforcement Administration publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.